The Centre has ordered probe after opposition members, journalists received messages on their iPhones, warning them of possible ‘state-spon...

The online drugstore plans to swallow a bitter pill in the hope that it can heal itself. The distress rights issue, if it goes through, wil...

Earlier in the day we broke the news that PharmEasy’s investors have taken control of the company as they plan a Rs 2,400 crore rights issu...

Byju’s woes seem to have no end. The company has suffered a series of setbacks over the last year, including ED raids and valuation markdow...

The calendar year 2022 saw online platforms like Flipkart, Amazon overtake offline retailers in shipments of smartphones from manufacturing...

AstraZeneca COVID vaccine is the same as Covishield which is used in India and several other countries.

SaaS startup Freshworks is hoping for a valuation of $9 billion for its US IPO. Uber Technologies has lost another lawsuit over its drivers...

PharmEasy, the only major Indian e-pharmacy that hasn't been bought out by a bigger firm, plans to launch its IPO before the end of the fis...

President Vladimir Putin has trumpeted the vaccine around the world, and said in March that Russia had signed agreements for the production...

RDIF has seen strong global interest in the vaccine and plans to conduct Phase 3 clinical trials in different countries, including Saudi Ar...

A black market has developed in Russia for an antiviral HIV drug explored as a possible treatment for COVID-19, the respiratory disease cau...

Buy Torrent Pharmaceuticals Ltd. at a price target of Rs 1560.0 .

Torrent Pharma said it plans further investments to expand the BPI facilities, including its research and development (R&D) capabilities, a...

Indian companies are expected to create 14.5% more new jobs this year than in 2015 with the pharmaceuticals and healthcare industry leading...

Bulk drug maker said it has received orders worth Rs 60 cr from Wockhardt and Cipla, for manufacturing cough syrup 'Recodex'.

Commenting on the pact, R-Pharm Chairman Alexey Repik said, "This agreement helps address unmet medical needs in important therapeutic area...